Sex differences in the efficacy of omalizumab in the treatment of chronic spontaneous urticaria
Background Omalizumab is shown to be effective in the treatment of chronic spontaneous urticaria (CSU), a disease with high personal and social impact. Sex differences in CSU are recognized with women more frequently affected. Scarce is the knowledge about response to omalizumab between sex groups....
Uloženo v:
| Hlavní autoři: | , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
SAGE Publishing
2021-12-01
|
| Edice: | International Journal of Immunopathology and Pharmacology |
| On-line přístup: | https://doi.org/10.1177/20587384211065870 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|